S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
SWOG Cancer Research Network
SWOG Cancer Research Network
Fudan University
Albert Einstein College of Medicine
M.D. Anderson Cancer Center
Ataturk University
Canadian Cancer Trials Group
Wake Forest University Health Sciences
GlaxoSmithKline
Alliance for Clinical Trials in Oncology
Royal Marsden NHS Foundation Trust
OHSU Knight Cancer Institute
University of Southern California
Beth Israel Medical Center
University of South Florida
National Cancer Institute (NCI)
Northwestern University
City of Hope Medical Center